WHO ICTRP trial
A randomized, double-blind, placebo-controlled, multicenter, dose-range…
NL-OMON47382 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON47382 |
|---|---|
| Public title | A randomized, double-blind, placebo-controlled, multicenter, dose-range, proof-of-concept, 24-week treatment study of IVA337 in adult subjects with nonalcoholic steatohepatitis (NASH) |
| Scientific title | A randomized, double-blind, placebo-controlled, multicenter, dose-range, proof-of-concept, 24-week treatment study of IVA337 in adult subjects with nonalcoholic steatohepatitis (NASH) - IVA_01_337_HNAS_16_002 |
| Primary sponsor | Inventiva S.A. |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 2 |
| Countries | Western Sahara |
| Conditions | hepatic steatosis. Non-alcoholic fatty liver disease;10013317;hepatic steatosis.;Non-alcoholic fatty liver disease |
| Interventions | For the patients with a liver biopsy performed within 6 months before screening, all diagnosis tests regarding the elimination of other causes of liver disease should have been performed before the patient is considered for inclusion in the… |
| Registration date | Jan 7, 2019 |
| Target size | 5 |
| Secondary IDs | 2016-001979-70;NL59629.072.16 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: